{
    "Ingredient": "SEMAGLUTIDE",
    "DF;Route": "SOLUTION;SUBCUTANEOUS",
    "Trade_Name": "OZEMPIC",
    "Applicant": "NOVO",
    "Strength": "8MG/3ML (2.68MG/ML)",
    "Appl_Type": "N",
    "Appl_No": 209637,
    "Product_No": 3,
    "TE_Code": null,
    "Approval_Date": "Mar 28, 2022",
    "RLD": "Yes",
    "RS": "Yes",
    "Type": "RX",
    "Applicant_Full_Name": "NOVO NORDISK INC"
}